Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangzhou Pientzehuang Shuixian Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of the Pientzehuang Group. The company specializes in the development, manufacture, and sale of Traditional Chinese Medicine (TCM) and chemical drugs, with a strong focus on over-the-counter (OTC) products. Its most iconic product is the Shuixian brand essential balm (Fengyoujing), which holds a significant market share in China and Southeast Asia. Beyond topical analgesics, the company produces a range of oral medications, ointments, and health supplements, leveraging its parent company's heritage in TCM while expanding into modern chemical pharmaceuticals. The company is listed on the National Equities Exchange and Quotations (NEEQ) and is recognized as a China Time-honored Brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shuixian.